Screener
CorMedix CRMD Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: CorMedix’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001410098-26-000021
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Convertible senior notes, net of deferred financing costs | 144,885 | 144,626 |
| Contingent Consideration, net of current portion | 102,397 | 99,101 |
| Other long-term liabilities | 2,530 | 2,839 |
| TOTAL LIABILITIES | $378,588 | $420,835 |
| COMMITMENTS AND CONTINGENCIES (Note 8) | ||
| STOCKHOLDERS’ EQUITY | ||
| Preferred stock - $0.001 par value: 2,000,000 shares authorized; 91,623 and 91,623 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | - | - |
| Common stock - $0.001 par value: 160,000,000 shares authorized; 78,395,299 and 79,260,667 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 78 | 79 |
Item 1. Unaudited Condensed Consolidated Financial Statements.
FAQ
- What is CorMedix's total liabilities?
- CorMedix (CRMD) reported total liabilities of $378.59M in Q1 2026.
- How has CorMedix's total liabilities changed year-over-year?
- CorMedix's total liabilities increased by 991.2% year-over-year, from $34.69M to $378.59M.
- What is the long-term trend for CorMedix's total liabilities?
- Over 5 years (2020 to 2025), CorMedix's total liabilities has grown at a 141.9% compound annual growth rate (CAGR), from $5.09M to $420.84M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about CorMedix's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude